Compare SLBT & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLBT | AGL |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Managed Health Care |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2025 | 2021 |
| Metric | SLBT | AGL |
|---|---|---|
| Price | $2.10 | $89.44 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $55.68 |
| AVG Volume (30 Days) | 46.5K | ★ 177.5K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 3.96 |
| Revenue | N/A | ★ $5,932,576,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | ★ N/A | $23.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.51 | $0.30 |
| 52 Week High | $6.25 | $133.04 |
| Indicator | SLBT | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 33.37 | 49.89 |
| Support Level | N/A | $93.01 |
| Resistance Level | $3.36 | $100.00 |
| Average True Range (ATR) | 0.25 | 4.87 |
| MACD | -0.01 | 0.60 |
| Stochastic Oscillator | 2.67 | 66.63 |
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.